Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

Journal of Clinical Investigation

Volumn 115, Issue 12, 2005, Pages 3602-3612

  Clute, Shalyn C ^a   Watkin, Levi B ^a   Cornberg, Markus ^a   Naumov, Yuri N ^a   Sullivan, John L ^a   Luzuriaga, Katherine ^a   Welsh, Raymond M ^a   Selin, Liisa K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYLISOLEUCYLGLYCYLPHENYLALANYLVALYLPHENYLALANYLTHREONYLLEUCINE; GLYCYLLEUCYLCYTEINYLTHREONYLLEUCYLVALYLALANYLMETHIONYLLEUCINE; HLA A2 ANTIGEN; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; INFLUENZA VIRUS A; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FLOW CYTOMETRY; GENES, MHC CLASS I; HERPESVIRUS 4, HUMAN; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; INFECTIOUS MONONUCLEOSIS; INFLUENZA A VIRUS; INTERFERON TYPE II; K562 CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; ORTHOMYXOVIRIDAE; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TIME FACTORS;

EID: 31044440222     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25078     Document Type: Article

References (57)

1. Hoagland, R.J. 1975. Infectious mononucleosis. Prim. Care. 2:295-307.
2. Young, L.S., and Rickinson, A.B. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4:757-768.
3. Rea, T.D., Russo, J.E., Katon, W., Ashley, R.L., and Buchwald, D.S. 2001. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J. Am. Board Fam. Pract. 14:234-242.
4. Auwaerter, P.G. 1999. Infectious mononucleosis in middle age. JAMA. 281:454-459.
5. Axelrod, P., and Finestone, A.J. 1990. Infectious mononucleosis in older adults. Am. Fam. Physician. 42:1599-1606.
6. Rickinson, A.B., and Kieff, E. 2001. Epstein-Barr virus. In Fields virology. D.M. Knipe and P.M. Howley, editors. Lippincott Williams & Wilkins. Philadelphia, Pennsylvania, USA. 2575-2627.
7. Silins, S.L., et al. 2001. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood. 98:3739-3744.
8. Andersson, J., et al. 1987. Acyclovir treatment in infectious mononucleosis: a clinical and virological study. Infection. 15(Suppl. 1):S14-S20.
9. Torre, D., and Tambini, R. 1999. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand. J. Infect. Dis. 31:543-547.
10. Brehm, M.A., et al. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-634.
11. Mongkolsapaya, J., et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921-927.
12. Nilges, K., et al. 2003. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. J. Virol. 77:5464-5474.
13. Selin, L.K., Nahill, S.R., and Welsh, R.M. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
14. Wedemeyer, H., Mizukoshi, E., Davis, A.R., Bennink, J.R., and Rehermann, B. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-11400.
15. Welsh, R.M., Selin, L.K., and Szomolanyi-Tsuda, E. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711-743.
16. Burrows, S.R., Khanna, R., Burrows, J.M., and Moss, D.J. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179:1155-1161.
17. Misko, I.S., et al. 1999. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. Proc. Natl. Acad. Sci. U. S. A. 96:2279-2284.
18. Strang, G., and Rickinson, A.B. 1987. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Eur. J. Immunol. 17:1007-1013.
19. Tomkinson, B.E., Maziarz, R., and Sullivan, J.L. 1989. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J. Immunol. 143:660-670.
20. Bousso, P., et al. 1998. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity. 9:169-178.
21. Cibotti, R., et al. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861-872.
22. Kim, S.K., et al. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201:523-533.
23. Gotch, F., Rothbard, J., Howland, K., Townsend, A., and McMichael, A. 1987. Cytotoxic T lymphocytes recognize a fragment of inf luenza virus matrix protein in association with HLA-A2. Nature. 326:881-882.
24. Callan, M.F. 2003. The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol. 16:3-16.
25. Catalina, M.D., Sullivan, J.L., Bak, K.R., and Luzuriaga, K. 2001. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection. J. Immunol. 167:4450-4457.
26. Steven, N.M., et al. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1605-1617.
27. Trautmann, L., et al. 2002. Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur. J. Immunol. 32:3181-3190.
28. Valitutti, S., Muller, S., Dessing, M., and Lanzavecchia, A. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
29. Lawson, T.M., et al. 2001. Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. Int. Immunol. 13:1383-1390.
30. Lawson, T.M., et al. 2001. Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int. Immunol. 13:1373-1381.
31. Lehner, P.J., et al. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181:79-91.
32. Moss, P.A., et al. 1991. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. U. S. A. 88:8987-8990.
33. Naumov, Y.N., Naumova, E.N., Hogan, K.T., Selin, L.K., and Gorski, J. 2003. A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responses. J. Immunol. 170:3994-4001.
34. Welsh, R.M., and Selin, L.K. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-426.
35. Doisne, J.M., et al. 2004. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J. Immunol. 173:2410-2418.
36. Williams, H., et al. 2004. Analysis of immune activation and clinical events in acute infectious mononucleosis. J. Infect. Dis. 190:63-71.
37. Urbani, S., et al. 2005. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201:675-680.
38. Chen, H.D., et al. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-1076.
39. Selin, L.K., Varga, S.M., Wong, I.C., and Welsh, R.M. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1705-1715.
40. Appay, V., et al. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
41. Callan, M.F., et al. 2000. CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J. Clin. Invest. 106:1251-1261.
42. Gillespie, G.M., et al. 2000. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 74:8140-8150.
43. Betts, M.R., et al. 2004. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172:6407-6417.
44. Madrenas, J., and Germain, R.N. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol. 8:83-101.
45. Sloan-Lancaster, J., and Allen, P.M. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
46. Foss, H.D., et al. 1994. Patterns of cytokine gene expression in infectious mononucleosis. Blood. 83:707-712.
47. Nakayama, T., et al. 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol. 78:1665-1674.
48. Zaitseva, M., et al. 2001. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus. Infect. Immun. 69:3817-3826.
49. De Rosa, S.C., et al. 2004. Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 173:5372-5380.
50. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
51. Xu, L., et al. 2004. Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J. Immunol. 173:721-725.
52. Rothman, A.L., and Ennis, F.A. 1999. Immunopathogenesis of Dengue hemorrhagic fever. Virology. 257:1-6.
53. Rabin, H., et al. 1981. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127:1852-1856.
54. Britten, C.M., et al. 2002. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J. Immunol. Methods. 259:95-110.
55. Arden, B., Clark, S.P., Kabelitz, D., and Mak, T.W. 1995. Human T-cell receptor variable gene segment families. Immunogenetics. 42:455-500.
56. Maslanka, K., Piatek, T., Gorski, J., Yassai, M., and Gorski, J. 1995. Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum. Immunol. 44:28-34.
57. Chothia, C., Boswell, D.R., and Lesk, A.M. 1988. The outline structure of the T-cell alpha beta receptor. EMBO J. 7:3745-3755.